U.S. Markets closed

Exelixis, Inc. (EXEL)

NASDAQ Global Select - NASDAQ Global Select Real Time Price. Currency in USD
Add to watchlist
27.00+0.63 (+2.39%)
At close: 4:00PM EDT

27.00 0.00 (0.00%)
After hours: 4:14PM EDT

People also watch
ARRYIMGNINCYCLDXSGEN
  • G
    Gator
    Gator
    I've never seen a group of more inpatient people. All everyone talks about is what the stock will do today, tomorrow or next week. Geez. Get some patience ams be happt with a long term above average return.
  • L
    Lance
    Lance
    Everyone please buy EXEL so Anonymous will shut up and try to cover his short position when this goes higher! 👍🏻
  • J
    John Dsouza
    John Dsouza
    Biotech sector looking to roar back this week and EXEL will lead the good mid-sized companies.
  • T
    Trent
    Trent
    Just noticed Anonymous is on a bunch of other yahoo biotech boards pumping his short ETF... might work elsewhere, EXEL is the next ONYX...positive HCC data and we will be at 60$/share easy!! Put up a short position or shut up!!
  • A
    Anonymous
    Anonymous
    EXEL is now retracing back to its 50 dma of 25.28. Once it breaches that level, it will then quickly drop to its 200 dma of 20.80.
    Sell everything and buy TZA......because this bubble is about to......POP
  • C
    Cosmo
    Cosmo
    Johnonymous, you leave me no choice. One more post from either you or yourself and mark my words I will blot out the sun on Monday leaving all of North America shrouded in darkness for about 2 hours!
  • A
    Anonymous
    Anonymous
    Can anyone tell me why this stick isnt $40 by now??? They are debt free and doing everything right and it just sits around $26-28!!! This is also a great buyout candidate. I just don't understand it..
  • M
    Marlon
    Marlon
    Anyone knows how long FDA has to respond to the sNDA filed by EXEL today? Or there is no deadline at all? Thanks
  • t
    tim
    tim
    NDA submission for 1st line RCC! Timing is impeccable, considering the BMY results yesterday.
  • B
    Biogemfinder
    Biogemfinder
    Very typical sell the news crowd is at work again. But you know how it end in the longer term -- say 3 days later? I now fully expect the PPS of EXEL to be above $30 mark before the next earnings. If there is positive data on HCC likely $35 before the earnings. Of course there is the possibility of good BO offer (which I personally dont prefer), or the market meltdown related to political upheaval.
  • J
    John Dsouza
    John Dsouza
    Probably last best chance to cover under $27 shorties (consider it a gift)!
  • A
    Anonymous
    Anonymous
    Nasdaq has a paltry 28.50 PT on EXEL which indicates that the shares are currently fully valued. Buy TZA... because the selling will continue for the next few weeks.....🐻
  • M
    Mark
    Mark
    Anonymous is now officially muted for me.
  • J
    John Dsouza
    John Dsouza
    Have that funny feeling in the bones that some NEWS is coming from EXEL very soon (and I don't mean BO news but rather data or FDA related)!
  • a
    antonio
    antonio
    please someone tell me what is going on with exel dropping..?
  • S
    Siavash Nikkhou
    Siavash Nikkhou
    $30 next week
  • r
    rtr
    rtr
    I see most people haven't figured it out yet.........Topline results released Tuesday from Bristol-Myers Squibb Co. (BMY) shows that the combination of two Bristol-Myers drugs, Opdivo and Yervoy, failed to show a statistically significant improvement over Pfizer's (PFE) Sutent in intermediate- and poor-risk kidney cancer patients. That's good news for Exelixis because previously released results already showed improvement from use of Cabometyx over Sutent in an identical sample of kidney cancer patients.
  • N
    Neil
    Neil
    EXEL up AH. I suspect the BM Kidney trial failure (opdivo and Yuervoy combo) didn't beat sunitinib, has folks thinking that the path may be clearing for Cabo in this indication? Anyone else agree?
  • m
    misha12345
    misha12345
    what happen? pulling back to red.
  • p
    paul
    paul
    Double catalysts this am!! New FDA Filing and Big FLOP for BMY. CHEERS TO ALL LONGS!!🍻🍻